Free shipping on all orders over $ 500

 About 1 result found for searched term "1228763-95-8" (0.034 seconds)

Cat.No.  Name Information
M21501 Monalizumab Monalizumab is a first-in-class immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab can be used in the study of head and neck squamous cell carcinoma (HNSCC).

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.